Sort
21,453 grants matching “tuberculosis”
Bacterial N-Acetyltransferases: Resistance to Regulation
$540,546John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2012 · AI
Trial of Vitamin D in HIV Progression
$540,325Wafaie W Fawzi · Harvard School Of Public Health · R01 · FY2013 · DK
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
$540,184James D. Bryers · University Of Washington · R01 · FY2023 · AI
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
$540,184James D. Bryers · University Of Washington · R01 · FY2022 · AI
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
$540,184James D. Bryers · University Of Washington · R01 · FY2024 · AI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a
$540,159Ronald Scott Braithwaite · New York University School Of Medicine · R01 · FY2009 · AA
T cell responses to CD1-restricted lipids in tuberculosis
$539,953David Branch Moody · Brigham And Women'S Hospital · R01 · FY2021 · AI
Core D In vitro Screening
$539,861Barry Neal Kreiswirth · Hackensack University Medical Center · U19 · FY2023 · AI
Multi-level and Intersectional Stigma and other Social Determinant Effects on TB Case Detection, Care, and Treatment Outcomes: The MISSED TB Outcomes Study
$539,769Andrew Medina-Marino · Desmond Tutu Hiv Foundation · R01 · FY2024 · AI
Investigating the basis of MAIT cell antigen potency
$539,763James McCluskey · University Of Melbourne · R01 · FY2024 · AI
Investigating the basis of MAIT cell antigen potency
$539,763James McCluskey · University Of Melbourne · R01 · FY2021 · AI
Phenotype MicroArray Analysis of Fastidious Pathogens
$539,754Barry Ronald Bochner · Biolog, Inc. · R42 · FY2008 · GM
TUBERCULOSIS GENOTYPING AND EVOLUTIONARY CONSORTIUM
$539,545Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2002 · AI
RECOMBINANT BCG MALARIA VACCINES
$539,499Yeshiva University · R01 · FY2000 · AI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB
$539,481Joshua T. Mattila · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Durability of systemic and lung immune correlates of BCG-induced protection against M. tuberculosis infection
$539,429Elisa Nemes · University Of Cape Town · R01 · FY2020 · AI
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$539,422Shruti H Mehta · Johns Hopkins University · R01 · FY2013 · DA
Microbiome in TB treatment response and disease resolution
$539,394Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2025 · AI
Project 3 - The Critical Role of Membrane Transport
$539,320Robert M Stroud · Texas A&M Agrilife Research · P01 · FY2019 · AI
Investigating the basis of MAIT cell antigen potency
$539,227James McCluskey · University Of Melbourne · R01 · FY2023 · AI
Investigating the basis of MAIT cell antigen potency
$539,227James McCluskey · University Of Melbourne · R01 · FY2022 · AI
Regulatory networks involved in Mycobacterium tuberculosis persistence
$539,085Petros C Karakousis · Johns Hopkins University · R01 · FY2009 · AI
B12 Trafficking and Inherited Defects
$539,014Ruma V Banerjee · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Molecular Chaperones and Protein Degradation
$538,985Alfred L Goldberg · Harvard Medical School · R01 · FY2013 · GM
MmpL3 as a target for novel anti-TB agents
$538,629Mary Jackson · Colorado State University · R01 · FY2015 · AI